Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

Early Breast Cancer Trailists’ Collaborative Group EBCTCG

Research output: Contribution to journalArticleAcademicpeer-review

312 Citations (Web of Science)

Abstract

Background bisphosphonates have profound effects on bone physiology, and could modify the process of metastasis. We undertook collaborative meta-analyses to clarify the risks and benefits of adjuvant bisphosphonate treatment in breast cancer.
Original languageEnglish
Pages (from-to)1353-1361
JournalLancet
Volume386
Issue number10001
DOIs
Publication statusPublished - 3 Oct 2015

Cite this